Traditional finance and crypto are coming closer together as President Donald Trump encourages more favorable regulation of digital assets.

AI16Z will rebrand to Eliza OS, reportedly on a request from Andreessen Horowitz, to avoid brand confusion. The AI agent project will focus on its growth as a framework, in a bid to retain its ...

In a report released today, Albert Lowe from Craig-Hallum maintained a Buy rating on SAB Biotherapeutics (SABS – Research Report). The ...

SAB BIO announced positive topline data from a Phase 1 trial of SAB-142 in a single-ascending dose among healthy volunteers. The study met its ...

SAB BIO's SAB-142 Phase 1 trial data supports its safety and pharmacodynamic activity, paving the way for a Phase 2b trial in T1D in 2025.

Arabian Contracting Co. (Al Arabia) obtained today, Feb. 3, a long-term Shariah-compliant facility worth SAR 972 million from ...

Unfortunately, that's been the case for longer term Southern Acids (M) Berhad (KLSE:SAB) shareholders ... When looking at investment returns, it is important to consider the difference between ...

This page features the latest news about the SAB Biotherapeutics stock. SABS stock touches 52-week low at $2.12 amid market challenges In a challenging market environment, Big Cypress Acquisition ...

KLSE:SAB Earnings Per Share Growth January 29th 2025 It might be well worthwhile taking a look at our free report on Southern Acids (M) Berhad's earnings, revenue and cash flow. When looking at ...